Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.40 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.40 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.40 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.40 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.40 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8991908 | 0.87 | LMNA (0.60) | LMNAALDH1A1GLATDP1KDM4E | |
| SCHEMBL35777 | 0.87 | LMNA (0.60) | LMNAALDH1A1GLATDP1KDM4E | |
| SCHEMBL1172155 | 0.83 | LMNA (0.53) | LMNAALDH1A1GLATDP1KDM4E | |
| SCHEMBL10623293 | 0.82 | LMNA (0.54) | LMNAALDH1A1GLATDP1KDM4E | |
| SCHEMBL10623290 | 0.82 | LMNA (0.54) | LMNAALDH1A1GLATDP1KDM4E | |
| SCHEMBL8037377 | 0.81 | GLA (0.56) | LMNAALDH1A1GLATDP1HDAC3 | |
| SCHEMBL221211 | 0.81 | TDP1 (0.64) | LMNAALDH1A1GLATDP1HDAC3 | |
| SCHEMBL3127156 | 0.81 | TDP1 (0.64) | LMNAALDH1A1GLATDP1HDAC3 | |
| SCHEMBL4535017 | 0.78 | LMNA (0.48) | LMNAALDH1A1GLATDP1KDM4E | |
| SCHEMBL2032564 | 0.77 | LMNA (0.52) | LMNAALDH1A1GLATDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6815498-B2 | BLOCK POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-09 | — | — | US | claimed |
| EP-1252203-B1 | METHOD FOR PRODUCING A POLYMERIC CONVERSION PRODUCT | BASF AG (DE) | 2004-03-17 | — | — | EP | claimed |
| US-20030018137-A1 | Method for producing a polymeric conversion product | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | US | claimed |
| US-7008990-B2 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-07 | — | — | US | disclosed |
| US-6815498-B2 | BLOCK POLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-11-09 | — | — | US | disclosed |
| US-20040034182-A1 | Method for the production of a polymerisation reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2004-02-19 | — | — | US | disclosed |
| US-20040014872-A1 | Bonding agent composition containing solid matter, with radically polymerised block copolymers | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-22 | — | — | US | disclosed |
| US-20030170306-A1 | Use of polymeric reaction product | BASF AKTIENGESELLSCHAFT (DE) | 2003-09-11 | — | — | US | disclosed |
| US-20030018137-A1 | Method for producing a polymeric conversion product | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-23 | — | — | US | disclosed |
| US-6506836-B1 | Reacting under free-radical conditions a reaction mixture comprising at least one free-radically reactable monomer (a) in the presence of at least one free-radical initiator and of a compound process for preparing a polymer using said reaction | BASF AKTIENGESELLSCHAFT (DE) | 2003-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030170306-A1 | Use of polymeric reaction product | OXSR1, OGFR, CBR1 | LMNA 1810/4885ALDH1A1 2250/4885GLA 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.